Glympse Bio raises more than $46M in Series B round for biosensor technology
The company is developing biosensors, initially for NASH, that could be used in place of liver biopsy and have applicability in development of drugs for the disease.
Alphabet’s life science arm just raised $1 billion
Alphabet CFO Ruth Porat and Silver Lake Managing Director Egon Durban will be nominated to join Verily's operating board.
presented by
Enhanced Direct Enrollment: Georgia Access and the Power of Partnership
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.
Orchard Therapeutics closes $150 million Series C round
The oversubscribed round comes just four months after acquisition of GSK's gene therapy portfolio.
Iora Health raises $100M with plans to double number of Medicare patients it serves
The funding comes as competition for the Medicare population by startup and growth-stage companies intensifies, not only from other technology-led healthcare organizations like Iora but also from the likes of CVS Health and more established companies like CareMore.
Verily eyes overseas markets with $800M infusion from Singapore
The investment could pave the way for the kind of joint ventures and collaborations that Verily has embarked on with the likes of Sanofi, GSK, and others.